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During the blood stage of their life cycle, malaria parasites invade and replicate within host eryth-
rocytes. Some parasites differentiate to formmale and female gametocytes, enabling transmission
to the insect vector. Two studies by Regev-Rudzki et al. andMantel et al. reveal an unexpected role
for cell-cell communication using extracellular vesicles in triggering the commitment of malaria
parasites toward sexual differentiation.Intercellular communication is a hallmark
of living organisms. Modes of com-
munication include cell-to-cell contact,
release of soluble signaling molecules,
and the most recently identified method
of cargo delivery in extracellular vesicles
(EVs). EVs have been shown to act as
intercellular communicators, transport
microRNAs, messenger RNAs, and pro-
teins and present antigens for the stimu-
lation of immune responses (The´ry et al.
2009). EVs also provide novel ap-
proaches for the development of diag-
nostics for infectious diseases and
cancer therapy (Schorey and Bhatnagar,
2008). Two major types of EVs that act
as intercellular communicators have
been defined: exosomes and microve-
sicles (MVs). Exosomes, which are 30–
100 nm membrane vesicles, are formed
by the endocytosis of segments of
the plasma membrane. The internalized
segments generate multivesicular
bodies (MVBs) that are released as
exosomes after fusion with the plasma
membrane. MVs, which are heteroge-
neous in shape and larger in size (100–
1,000 nm), originate by budding
from the plasma membrane. Two articles
now demonstrate that EVs secreted
by P. falciparum-infected red blood
cells (iRBCs) act as intercellular commu-
nicators (Regev-Rudzki et al., 2013;
Mantel et al., 2013). In this issue of Cell,
Regev-Rudzki et al. (2013) show that,
after exposure to drug pressure,
P. falciparum ring-stage parasites release
exosome-like vesicles of 80–120 nm thatcan transfer nucleic acid cargo to their
neighbors, conferring antibiotic resis-
tance. In a related study in Cell Host &
Microbe, Mantel et al. (2013) describe
the quantitative release of MVs of 100–
400 nm from P. falciparum schizont-stage
parasites before egress. Remarkably,
both articles demonstrate that the trans-
fer of exosome-like vesicles and MVs
to other iRBCs induces gametocytogene-
sis, providing the parasite a route for
escaping a hostile environment.
The dissemination of drug resistance
to sensitive cells by the transfer of
proteins by EVs has been described
previously (Gong et al., 2012). Regev-
Rudzki et al. (2013) now describe elegant
experiments that demonstrate that plas-
mids carrying genes encoding drug
resistance markers as well as fluorescent
reporter proteins can be transferred
from one P. falciparum iRBC to another
through exosome-like vesicles that are
secreted during blood-stage growth.
The experiments used different trans-
genic P. falciparum lines containing
episomally maintained or integrated
plasmids with genes that confer resis-
tance to the antimalarial drugs
blasticidin (Bs) or WR99210 (WR). When
transgenic lines were cultured indi-
vidually in the presence of Bs+WR,
neither transgenic line survived the dual
drug selection. In striking contrast,
when both transgenic lines were cocul-
tured in presence of Bs+WR, parasites
that were resistant to both antibiotics
appeared after 5 days of culture. TakingCelladvantage of transwell techniques, the
authors demonstrated that the transfer
of such genetic material does not require
physical contact and is dependent on
the secretion and subsequent uptake of
exosome-like vesicles.
A genetic screen had previously
identified a number of parasite proteins
that were required for the secretion of
P. falciparum variant surface antigen
PfEMP1 to the surface of iRBCs (Maier
et al., 2008). Deletion of one of the genes
involved in PfEMP1 trafficking, which
encodes PfEMP1 trafficking protein 2
(PfPTP2), blocked both the secretion
and receipt of parasite-derived exo-
some-like vesicles. PfPTP2 was localized
to vesicles budding from the Maurer’s
cleft in P. falciparum-infected erythro-
cytes. The precise mechanism by which
such vesicles bud off from the Maurer’s
cleft to form exosome-like vesicles
remains to be understood.
Both exosomes and MVs have been
previously described in human and
rodent malaria parasites. Exosomes and
MVs derived from rodent malaria infec-
tions contain parasite proteins and
induce long-lasting protective immune
responses and systemic inflammation
(Couper et al., 2010; Martin-Jaular
et al., 2011). MVs were also detected
in peripheral blood of P. falciparum as
well as P. vivax patients (Nantakomol
et al., 2011; Campos et al., 2010). In
the case of P. falciparum, the presence
of MVs was associated with severe
malaria, suggesting that they play a role153, May 23, 2013 ª2013 Elsevier Inc. 945
Figure 1. Exosome-like Vesicles Secreted by P. falciparum Ring-
Stage Parasites and Microvesicles Secreted by P. falciparum
Schizonts Induce Sexual Differentiationin malaria pathogenesis
(Nantakomol et al., 2011).
Mantel et al. (2013) show
that released MVs from
P. falciparum iRBCs (RMVs)
contain a distinct pattern of
parasite antigens, as de-
tected by western blot anal-
ysis with pooled immune
sera (Mantel et al., 2013).
Moreover, proteomic analysis
of RMVs released from
P. falciparum iRBCs by mass
spectrometry revealed the
presence of canonical RBC
proteins that are commonly
enriched in MVs released
from uninfected RBCs. In
addition, RMVs released
from iRBCs contain parasite
proteins localized in the
RBC and parasitophorous
vacuolar membranes as well
as invasion-related parasiteproteins that are found in apical organ-
elles of merozoites. When RMVs derived
from iRBCs are used to stimulate periph-
eral blood mononuclear cells (PBMCs),
they stimulate monocytes (CD14+) and
induce dose-dependent production
of cytokines. Altogether, these results
suggest that EVs released from iRBCs
play a role in antigen presentation and
themodulation of host immune responses
in malaria.
Most importantly, both studies demon-
strate that the exchange of exosome-like
vesicles and RMVs by P. falciparum
iRBCs appears to trigger sexual dif-
ferentiation, leading to the appearance
of gametocytes in parasite culture
(Figure 1). These new players add to
reports on the manipulation of culture
conditions and the addition of chemical
compounds that have been shown
previously to trigger gametocytogenesis
in vitro (Roncale´s et al., 2012). Notably,
the rate of formation of exosome-like
vesicles and RMVs as well as the rate
of gametocyte formation increase signif-
icantly in the presence of drug pressure.
Thus, this novel mode of intercellular
communication provides the parasite a
route for sensing and escaping a hostile
environment.
The articles discussed above raise
a number of interesting questions for
further study. First of all, it is essential946 Cell 153, May 23, 2013 ª2013 Elsevier Into demonstrate that exosome-like vesi-
cles and RMVs derived from natural
infections are capable of inducing
gametocytogenesis. Next, it would be
useful to employ accepted markers for
microparticles, MVs, and exosomes
(http://www.microvesicles.org/) in order
to determine the precise nature of the
vesicles released from P. falciparum-
infected erythrocytes. In addition, more
precise kinetics and quantitation of
vesicle secretion are needed in order
to determine a minimal threshold that
can induce gametocytogenesis and im-
mune responses. Importantly, the sizes
of EVs and their origin reported by the
two studies are different. Exosome-like
vesicles have a diameter of 80–120 nm
and are secreted from ring stages,
whereas RMVs have a diameter of
100–400 nm and are secreted by schiz-
onts. Is the biogenesis of exosome-like
vesicles and RMVs similar? Do seg-
ments of the RBC membrane of in-
fected erythrocytes undergo endocy-
tosis, and do the vesicles created by
such a process fuse with the RBC
membrane, leading to the release of
exosome-like vesicles? On the other
hand, do RMVs bud off from the iRBC
membrane as reported for other MVs?
What is the role of Maurer’s cleft in
the process of EV secretion? What are
the signaling pathways that trigger thec.production of exosome-like
vesicles and RMVs from
iRBCs in response to drug
pressure? Do similar pro-
cesses come into play
when malaria parasites are
under immune pressure?
What is the cargo carried
by exosome-like vesicles
and RMVs that provides
the signal for the triggering
of gametocytogenesis? The
signaling pathways that
lead to gametocytogenesis
in response to the fusion
of exosome-like vesicles or
RMVs also remain to be
understood. It is clear that
malaria parasites can com-
municate with each other
through EVs in order to
pass on signals that lead
to sexual differentiation.
Now, we need to understandthe language they use for such
communication.
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